Ignite Creation Date:
2024-05-06 @ 1:35 PM
Last Modification Date:
2024-10-26 @ 1:16 PM
Study NCT ID:
NCT04065269
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2019-08-01
Brief Title:
ATr Inhibitor in Combination With OlaparibDurvalumab MEDI4736 in Gynaecological Cancers With ARId1A Loss or no Loss
Sponsor:
Institute of Cancer Research United Kingdom
Organization:
Institute of Cancer Research United Kingdom
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-11-27
Start Date Type:
ACTUAL
Primary Completion Date:
2026-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-04
Completion Date Type:
ESTIMATED
First Submit Date:
2019-08-01
First Submit QC Date:
August 21 2019
Study First Post Date:
2019-08-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-09
Last Update Post Date:
2024-07-11
Last Update Post Date Type:
ACTUAL